See more : Koyou Rentia Co., Ltd. (7081.T) Income Statement Analysis – Financial Results
Complete financial analysis of NanoString Technologies, Inc. (NSTG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of NanoString Technologies, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Precision Drilling Corporation (PDS) Income Statement Analysis – Financial Results
- Nanjing Quanxin Cable Technology Co., Ltd. (300447.SZ) Income Statement Analysis – Financial Results
- Ninety One Group (NINTF) Income Statement Analysis – Financial Results
- Navigator Holdings Ltd. (NVGS) Income Statement Analysis – Financial Results
- Instacart (Maplebear Inc.) (CART) Income Statement Analysis – Financial Results
NanoString Technologies, Inc. (NSTG)
About NanoString Technologies, Inc.
NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics. It has collaboration with Lam Research Corporation for the research and development of Hyb & Seq technologies; Celgene Corporation for developing LymphMark, an in vitro diagnostic for the treatment of diffuse large B-cell lymphoma; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 127.26M | 145.09M | 117.32M | 125.57M | 106.73M | 114.91M | 86.49M | 62.67M | 47.59M | 31.40M | 22.97M | 17.80M | 11.73M | 34.42M |
| Cost of Revenue | 65.48M | 68.30M | 52.41M | 44.04M | 36.33M | 31.88M | 30.25M | 26.13M | 21.15M | 15.01M | 12.36M | 9.78M | 9.13M | 21.12M |
| Gross Profit | 61.79M | 76.78M | 64.91M | 81.53M | 70.40M | 83.03M | 56.24M | 36.54M | 26.44M | 16.39M | 10.61M | 8.02M | 2.60M | 13.30M |
| Gross Profit Ratio | 48.55% | 52.92% | 55.33% | 64.93% | 65.96% | 72.26% | 65.03% | 58.31% | 55.56% | 52.21% | 46.19% | 45.07% | 22.18% | 38.64% |
| Research & Development | 70.84M | 69.50M | 62.86M | 68.04M | 61.60M | 46.89M | 34.72M | 24.60M | 21.40M | 14.98M | 11.64M | 8.99M | 7.55M | 19.09M |
| General & Administrative | 133.83M | 110.70M | 86.70M | 90.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 9.30M | 4.80M | 3.40M | 5.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 143.13M | 115.50M | 90.10M | 96.20M | 78.20M | 74.33M | 62.70M | 53.19M | 51.06M | 29.91M | 15.49M | 9.53M | 8.03M | 36.90M |
| Other Expenses | -1.92M | -20.00K | -971.00K | -929.00K | -1.66M | 183.00K | -515.00K | -389.00K | -147.00K | -66.00K | -29.00K | 80.00K | 254.00K | 0.00 |
| Operating Expenses | 213.97M | 185.01M | 152.95M | 164.23M | 139.79M | 121.22M | 97.42M | 77.78M | 72.47M | 44.89M | 27.12M | 18.52M | 15.57M | 55.98M |
| Cost & Expenses | 279.45M | 253.31M | 205.36M | 208.27M | 176.13M | 153.10M | 127.67M | 103.91M | 93.62M | 59.90M | 39.48M | 28.30M | 24.70M | 77.10M |
| Interest Income | 2.41M | 649.00K | 1.74M | 2.82M | 1.33M | 809.00K | 390.00K | 233.00K | 272.00K | 68.00K | 21.00K | 10.00K | 29.00K | 0.00 |
| Interest Expense | 7.54M | 7.49M | 15.41M | 8.49M | 7.43M | 6.15M | 5.67M | 4.02M | 4.14M | 1.94M | 804.00K | 599.00K | 94.00K | -1.89M |
| Depreciation & Amortization | 492.00K | 629.00K | 773.00K | 1.89M | 4.07M | 3.35M | 2.98M | 2.38M | 1.54M | 1.78M | 1.95M | 1.45M | 972.00K | 0.00 |
| EBITDA | -143.58M | -101.73M | -88.05M | -82.70M | -65.65M | -34.84M | -38.32M | -39.02M | -44.31M | -26.51M | -14.96M | -8.88M | -11.70M | -42.68M |
| EBITDA Ratio | -119.20% | -74.16% | -74.39% | -64.36% | -65.32% | -32.38% | -47.75% | -66.06% | -96.44% | -90.74% | -63.42% | -50.29% | -99.89% | -123.99% |
| Operating Income | -152.18M | -108.23M | -88.05M | -82.70M | -69.39M | -38.20M | -41.18M | -41.24M | -46.02M | -28.50M | -16.51M | -10.50M | -12.97M | -42.68M |
| Operating Income Ratio | -119.58% | -74.59% | -75.05% | -65.86% | -65.02% | -33.24% | -47.61% | -65.81% | -96.70% | -90.75% | -71.86% | -58.97% | -110.59% | -123.99% |
| Total Other Income/Expenses | -7.04M | -6.86M | -21.78M | 42.27M | -7.76M | -5.16M | -5.80M | -4.17M | -4.02M | -784.00K | -1.20M | -436.00K | 204.00K | -1.44M |
| Income Before Tax | -159.23M | -115.09M | -109.83M | -40.43M | -77.15M | -43.36M | -46.97M | -45.42M | -50.04M | -29.28M | -17.71M | -10.93M | -12.77M | -44.12M |
| Income Before Tax Ratio | -125.12% | -79.32% | -93.61% | -32.20% | -72.28% | -37.73% | -54.31% | -72.47% | -105.14% | -93.24% | -77.08% | -61.42% | -108.85% | -128.17% |
| Income Tax Expense | 317.00K | 167.00K | 253.00K | 269.00K | 249.00K | 204.00K | 116.00K | 166.00K | 2.45M | 99.00K | 775.00K | 679.00K | 348.00K | 5.00K |
| Net Income | -159.54M | -115.25M | -110.08M | -40.70M | -77.40M | -43.56M | -47.09M | -45.58M | -50.04M | -29.28M | -17.71M | -10.93M | -12.77M | -44.11M |
| Net Income Ratio | -125.37% | -79.44% | -93.83% | -32.41% | -72.52% | -37.91% | -54.45% | -72.74% | -105.14% | -93.24% | -77.08% | -61.42% | -108.85% | -128.16% |
| EPS | -3.44 | -2.54 | -2.82 | -1.18 | -2.78 | -1.84 | -2.34 | -2.40 | -2.80 | -3.83 | -1.93 | -1.19 | -1.59 | -0.95 |
| EPS Diluted | -3.44 | -2.54 | -2.82 | -1.18 | -2.78 | -1.84 | -2.34 | -2.40 | -2.80 | -3.83 | -1.93 | -1.19 | -1.59 | -0.95 |
| Weighted Avg Shares Out | 46.41M | 45.30M | 39.08M | 34.59M | 27.88M | 23.73M | 20.12M | 19.03M | 17.84M | 7.64M | 9.17M | 9.17M | 8.02M | 46.66M |
| Weighted Avg Shares Out (Dil) | 46.41M | 45.30M | 39.08M | 34.59M | 27.88M | 23.73M | 20.12M | 19.03M | 17.84M | 7.64M | 9.17M | 9.17M | 8.02M | 46.66M |
NanoString Technologies Releases Operating Results for Second Quarter of 2022
NanoString to Webcast Presentations from Two Upcoming Healthcare Conferences
Wall Street Analysts See a 172% Upside in NanoString (NSTG): Can the Stock Really Move This High?
NanoString to Release Second Quarter 2022 Operating Results and Host Conference Call on Thursday, August 4, 2022
NanoString to Release Second Quarter 2022 Operating Results and Host Conference Call on Thursday, August 4, 2022
NanoString Unveils AtoMx Spatial Informatics Portal at the 2022 Advances in Genome Biology and Technology (AGBT) General Meeting
NanoString to Unveil New Platforms and Showcase Spatial Biology Research at 2022 Advances in Genome Biology and Technology (AGBT) General Meeting
NanoString Launches Integrated Informatics to Facilitate Spatial Biology Research Using Next Generation Sequencing
NanoString to Webcast Presentation from the UBS 2022 Global Healthcare Conference
NanoString Technologies, Inc. (NSTG) CEO Brad Gray on Q1 2022 Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports